Amgen INC.
Pharmaceutical Company
Based in CA
🤖
AI Overview
With $1.4M in lobbying spend across 27 quarterly filings, Amgen INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $100K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $150K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $150K |
| 2025 | $150K |
Lobbying Firms
BGR GOVERNMENT AFFAIRS
What They Lobby For
- Provide advice and strategic counsel with regard to regulations that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, 340b, FDA regulatory issues, and corporate tax reform.
- Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, FDA regulatory issues, and corporate tax reform.
- Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, FDA regulatory issues, and corporate tax reform.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.